Abscess Aspiration
Study Protocol for A Randomized Controlled Trial of Incision and Drainage Versus Ultrasound-Guided Needle Aspiration for Uncomplicated Skin Abscesses
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
Incision and drainage (I\&D) is the standard guideline treatment of uncomplicated skin abscesses (a boil or bumo beneath the skin). Ultrasound-guided needle aspiration (USGNA) is a minimally invasive and less painful alternative treatment, but has not been validated as non-inferior to I\&D. Multiple studies have shown successful treatment with USGNA of breast, face, neck, and/or trunk abscesses in combination with oral antibiotics with success rates as high as 97%. In 2011 Gaspari et al. published a landmark article on the use of USGNA for skin abscesses. In this randomized controlled trial, USGNA and I\&D had failure rates of 74% and 20% respectively, which makes USGNA an unappealing treatment option. However, the study had several methodological issues that likely biased the results in favor of I\&D, including the following: 1) aspiration was performed with an 18-gauge needle which is often too small to aspirate thick purulence (or pus); 2) failure to fully aspirate all abscess contents was a priori defined as treatment failure rather than strictly clinical outcomes; 3) the abscess aspiration procedure was not standardized; and 4) post-intervention oral antibiotic therapy was not used on all patients. The main hypothesis is that a modified protocol of the Gaspari et al. USGNA study to address these flaws will demonstrate a failure of USGNA comparable to I\&D for the treatment of uncomplicated skin abscesses. First, the study will standardize the use of larger 14-gauge needle on all USGNAs. Second, USGNA intervention failure need not be defined as the inability to completely aspirate all abscess cavity contents under ultrasound guidance. Previous studies have demonstrated clinical success with USGNA of skin abscesses without applying the rigid failure criteria chosen by Gaspari et al. There is only one study in the literature to suggest that there is no correlation between a small quantity of residual abscess contents post-USGNA and ultimate clinical failure, however, there are no studies which specifically address this clinical question. In this study, initial treatment failure of USGNA will be defined as the inability to aspirate any purulent material. Third, treatment outcomes in this study will be determined by clinical resolution of abscess at the study endpoint of 7-10 days, which is a well-established timeline for anticipated abscess healing and endpoint clinical follow-up. Fourth, ultrasound fellowship-trained emergency physicians will perform USGNA in standardized fashion on all enrolled patients. Lastly, post-intervention oral antibiotic with methicillin-resistant Staphylococcus aureus (MRSA) coverage will be provided and compliance closely monitored throughout the study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jun 2020
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 10, 2019
CompletedFirst Posted
Study publicly available on registry
October 15, 2019
CompletedStudy Start
First participant enrolled
June 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedMay 19, 2020
May 1, 2020
7 months
October 10, 2019
May 18, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Abscess cure or treatment failure
Treatment cure will be defined by the complete resolution of the abscess based on clinical signs and symptoms (no or minimal tenderness, erythema, fever, wound drainage, warmth, fluctuance, or induration) at the 7- to 10-day follow-up. Treatment failure will be defined by: fever (attributable to the infection), persistent or increased size \>25% of the original abscess, requiring conversion to I\&D (USGNA intervention group) or repeat I\&D (I\&D intervention group), requiring additional antibiotics, or requiring hospital admission within 7-10 days after treatment. Participants who either withdraw from the trial or are lost to follow-up before a determination of final outcome will be classified as treatment failure.
7-10 days
Secondary Outcomes (5)
Patient Satisfaction
Baseline (Day 1)
Patient Comfort Level
Baseline (Day 1)
Abscess Characteristics and Correlation with Treatment Failure
Baseline (Day 1)
Abscess Reoccurrence
Day 21-30
Abscess Site infection
Day 21-30
Study Arms (2)
Surgical I&D Procedure
ACTIVE COMPARATORThe abscess cavity will be evaluated thoroughly with ultrasonography. The site will be prepared and draped. The skin surface will be infiltrated with local anesthetic with a 25-gauge needle. The treating clinician may provide ultrasound-guided regional anesthesia for procedural analgesia at their discretion. Incision of the skin surface with a number 11-blade scalpel will be performed over the largest area of infection; the incision will be extended into the abscess cavity. A blunt instrument will then be used to break up internal loculations if present. Repeated instrumentation through the initial incision or extension of the original incision will be performed if needed. Lastly, iodoform packing will be inserted through the incision into the cavity. The decision to send the abscess contents for microbiological culture and susceptibility analysis will be at the discretion of the treating clinician.
Ultrasound-guided Needle Aspiration Procedure
EXPERIMENTALThe abscess cavity will be evaluated thoroughly with US. The site will be prepared and draped. The skin surface and anticipated needle track will be infiltrated with local anesthetic with a 25g needle. The treating clinician may provide ultrasound-guided regional anesthesia for procedural analgesia at their discretion. Under direct US-guided visualization, a 14g 2in steel needle attached to a 40mL syringe will be advanced into the abscess cavity with manual negative pressure. The needle tract will be extended obliquely 2-3 cm between the skin and abscess to prevent fistulization. Purulent material will be aspirated until no further purulence can be aspirated. Multiple aspiration attempts on the initial visit will be permitted to maximally drain the abscess cavity. Additionally, irrigation of the abscess cavity with sterile saline will be permitted to break up internal loculations if present, as has reported previously for trunk and breast abscesses.
Interventions
The intervention under investigation utilizes an ultrasound-guided needle to less invasively drain an abscess.
The current standard procedure to drain an abscess of purulent material.
Eligibility Criteria
You may qualify if:
- Abscesses must be verified by physical examination and bedside ultrasound.
- Patients with clinical history of diabetes mellitus and previous diagnosis of MRSA will be included.
You may not qualify if:
- Patients will be excluded if age less than age 18 or pregnant.
- Patient or legal guardian is unable to give consent.
- Patients with no means of clinical follow-up will be excluded.
- Complicated abscesses, defined as an abscess with associated sepsis, lymphangitis, or osteomyelitis, requiring intravenous antibiotic therapy, requiring hospital admission, previous surgical drainage at site of abscess, overlying skin lesion/fistula/ulceration with the exception of cellulitis, perforated or actively draining abscess, duration of symptoms \> 5 days,1,28 and/or multiple concurrent abscesses that can be clinically regarded as chronic in nature will be excluded.
- \) Abscess locations which will be excluded are dental, peritonsillar, anorectal, genital/inguinal, axillary if suspicion for chronic hidradenitis suppurativa, or pilonidal/intragluteal at the base of the coccyx.
- \) Abscesses greater in size than 3x3x3 cm in any dimension will be excluded. \[It has been suggested extensively in the surgical literature that an abscess diameter \>3 cm should have surgical/catheter-drainage as the initial management instead of needle aspiration\]2,5,15,19,27,33 \[It has been reported that abscesses \>3 cm in size have increased failure rates\]15 6) Abscess depth is greater than maximal needle length. 7) Patients with immunosuppression from following clinical conditions will be excluded: HIV, cancer on active chemotherapy.
- \) Patients with active history of IV drug use will be excluded.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (34)
Barron AU, Luk S, Phelan HA, Williams BH. Do acute-care surgeons follow best practices for breast abscess management? A single-institution analysis of 325 consecutive cases. J Surg Res. 2017 Aug;216:169-171. doi: 10.1016/j.jss.2017.05.013. Epub 2017 May 10.
PMID: 28807202BACKGROUNDBerna-Serna JD, Madrigal M, Berna-Serna JD. Percutaneous management of breast abscesses. An experience of 39 cases. Ultrasound Med Biol. 2004 Jan;30(1):1-6. doi: 10.1016/j.ultrasmedbio.2003.10.003.
PMID: 14962601BACKGROUNDBlaivas M. Ultrasound-guided breast abscess aspiration in a difficult case. Acad Emerg Med. 2001 Apr;8(4):398-401. doi: 10.1111/j.1553-2712.2001.tb02122.x.
PMID: 11282679BACKGROUNDChandika AB, Gakwaya AM, Kiguli-Malwadde E, Chalya PL. Ultrasound Guided Needle Aspiration versus Surgical Drainage in the management of breast abscesses: a Ugandan experience. BMC Res Notes. 2012 Jan 6;5:12. doi: 10.1186/1756-0500-5-12.
PMID: 22226127BACKGROUNDChristensen AF, Al-Suliman N, Nielsen KR, Vejborg I, Severinsen N, Christensen H, Nielsen MB. Ultrasound-guided drainage of breast abscesses: results in 151 patients. Br J Radiol. 2005 Mar;78(927):186-8. doi: 10.1259/bjr/26372381.
PMID: 15730981BACKGROUNDChuck EA, Frazee BW, Lambert L, McCabe R. The benefit of empiric treatment for methicillin-resistant Staphylococcus aureus. J Emerg Med. 2010 Jun;38(5):567-71. doi: 10.1016/j.jemermed.2007.11.037. Epub 2008 Jun 2.
PMID: 18514468BACKGROUNDDixon JM. Repeated aspiration of breast abscesses in lactating women. BMJ. 1988 Dec 10;297(6662):1517-8. doi: 10.1136/bmj.297.6662.1517. No abstract available.
PMID: 3147056BACKGROUNDDixon JM. Outpatient treatment of non-lactational breast abscesses. Br J Surg. 1992 Jan;79(1):56-7. doi: 10.1002/bjs.1800790120.
PMID: 1737278BACKGROUNDElagili F, Abdullah N, Fong L, Pei T. Aspiration of breast abscess under ultrasound guidance: outcome obtained and factors affecting success. Asian J Surg. 2007 Jan;30(1):40-4. doi: 10.1016/S1015-9584(09)60126-3.
PMID: 17337370BACKGROUNDFrazee BW, Lynn J, Charlebois ED, Lambert L, Lowery D, Perdreau-Remington F. High prevalence of methicillin-resistant Staphylococcus aureus in emergency department skin and soft tissue infections. Ann Emerg Med. 2005 Mar;45(3):311-20. doi: 10.1016/j.annemergmed.2004.10.011.
PMID: 15726056BACKGROUNDGarg P, Rathee SK, Lal A. Ultrasonically guided percutaneous drainage of breast abscess. J Indian Med Assoc. 1997 Nov;95(11):584-5.
PMID: 9567588BACKGROUNDGaspari RJ, Resop D, Mendoza M, Kang T, Blehar D. A randomized controlled trial of incision and drainage versus ultrasonographically guided needle aspiration for skin abscesses and the effect of methicillin-resistant Staphylococcus aureus. Ann Emerg Med. 2011 May;57(5):483-91.e1. doi: 10.1016/j.annemergmed.2010.11.021. Epub 2011 Jan 15.
PMID: 21239082BACKGROUNDGiess CS, Golshan M, Flaherty K, Birdwell RL. Clinical experience with aspiration of breast abscesses based on size and etiology at an academic medical center. J Clin Ultrasound. 2014 Nov-Dec;42(9):513-21. doi: 10.1002/jcu.22191. Epub 2014 Jun 27.
PMID: 24975466BACKGROUNDHerzon FS. Needle aspiration of nonperitonsillar head and neck abscesses. A six-year experience. Arch Otolaryngol Head Neck Surg. 1988 Nov;114(11):1312-4. doi: 10.1001/archotol.1988.01860230106035.
PMID: 3166766BACKGROUNDHook GW, Ikeda DM. Treatment of breast abscesses with US-guided percutaneous needle drainage without indwelling catheter placement. Radiology. 1999 Nov;213(2):579-82. doi: 10.1148/radiology.213.2.r99nv25579.
PMID: 10551245BACKGROUNDImperiale A, Zandrino F, Calabrese M, Parodi G, Massa T. Abscesses of the breast. US-guided serial percutaneous aspiration and local antibiotic therapy after unsuccessful systemic antibiotic therapy. Acta Radiol. 2001 Mar;42(2):161-5. doi: 10.1080/028418501127346666.
PMID: 11259943BACKGROUNDKang YD, Kim YM. Comparison of needle aspiration and vacuum-assisted biopsy in the ultrasound-guided drainage of lactational breast abscesses. Ultrasonography. 2016 Apr;35(2):148-52. doi: 10.14366/usg.15041. Epub 2015 Dec 8.
PMID: 26753603BACKGROUNDKarstrup S, Nolsoe C, Brabrand K, Nielsen KR. Ultrasonically guided percutaneous drainage of breast abscesses. Acta Radiol. 1990 Mar;31(2):157-9.
PMID: 2196923BACKGROUNDKarstrup S, Solvig J, Nolsoe CP, Nilsson P, Khattar S, Loren I, Nilsson A, Court-Payen M. Acute puerperal breast abscesses: US-guided drainage. Radiology. 1993 Sep;188(3):807-9. doi: 10.1148/radiology.188.3.8351352.
PMID: 8351352BACKGROUNDKjaer S, Rud B, Bay-Nielsen M. Ultrasound-guided drainage of subcutaneous abscesses on the trunk is feasible. Dan Med J. 2013 Apr;60(4):A4601.
PMID: 23651712BACKGROUNDLeborgne F, Leborgne F. Treatment of breast abscesses with sonographically guided aspiration, irrigation, and instillation of antibiotics. AJR Am J Roentgenol. 2003 Oct;181(4):1089-91. doi: 10.2214/ajr.181.4.1811089.
PMID: 14500237BACKGROUNDMay L, Harter K, Yadav K, Strauss R, Abualenain J, Keim A, Schmitz G. Practice patterns and management strategies for purulent skin and soft-tissue infections in an urban academic ED. Am J Emerg Med. 2012 Feb;30(2):302-10. doi: 10.1016/j.ajem.2010.11.033. Epub 2011 Jan 28.
PMID: 21277138BACKGROUNDMay LS, Zocchi M, Zatorski C, Jordan JA, Rothman RE, Ware CE, Eells S, Miller L. Treatment Failure Outcomes for Emergency Department Patients with Skin and Soft Tissue Infections. West J Emerg Med. 2015 Sep;16(5):642-52. doi: 10.5811/westjem.2015.7.26213. Epub 2015 Oct 20.
PMID: 26587085BACKGROUNDMoran GJ, Krishnadasan A, Gorwitz RJ, Fosheim GE, McDougal LK, Carey RB, Talan DA; EMERGEncy ID Net Study Group. Methicillin-resistant S. aureus infections among patients in the emergency department. N Engl J Med. 2006 Aug 17;355(7):666-74. doi: 10.1056/NEJMoa055356.
PMID: 16914702BACKGROUNDO'Hara RJ, Dexter SP, Fox JN. Conservative management of infective mastitis and breast abscesses after ultrasonographic assessment. Br J Surg. 1996 Oct;83(10):1413-4. doi: 10.1002/bjs.1800831028.
PMID: 8944458BACKGROUNDOlderog CK, Schmitz GR, Bruner DR, Pittoti R, Williams J, Ouyang K. Clinical and epidemiologic characteristics as predictors of treatment failures in uncomplicated skin abscesses within seven days after incision and drainage. J Emerg Med. 2012 Oct;43(4):605-11. doi: 10.1016/j.jemermed.2011.09.037. Epub 2012 Jun 12.
PMID: 22698825BACKGROUNDOzseker B, Ozcan UA, Rasa K, Cizmeli OM. Treatment of breast abscesses with ultrasound-guided aspiration and irrigation in the emergency setting. Emerg Radiol. 2008 Mar;15(2):105-8. doi: 10.1007/s10140-007-0683-0. Epub 2008 Jan 10.
PMID: 18193464BACKGROUNDSchwarz RJ, Shrestha R. Needle aspiration of breast abscesses. Am J Surg. 2001 Aug;182(2):117-9. doi: 10.1016/s0002-9610(01)00683-3.
PMID: 11574080BACKGROUNDSinger AJ, Talan DA. Management of skin abscesses in the era of methicillin-resistant Staphylococcus aureus. N Engl J Med. 2014 Mar 13;370(11):1039-47. doi: 10.1056/NEJMra1212788. No abstract available.
PMID: 24620867BACKGROUNDStevens DL, Bisno AL, Chambers HF, Dellinger EP, Goldstein EJ, Gorbach SL, Hirschmann JV, Kaplan SL, Montoya JG, Wade JC. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the infectious diseases society of America. Clin Infect Dis. 2014 Jul 15;59(2):147-59. doi: 10.1093/cid/ciu296. Epub 2014 Jun 18.
PMID: 24947530BACKGROUNDTalan DA, Mower WR, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, Steele MT, Rothman RE, Hoagland R, Moran GJ. Trimethoprim-Sulfamethoxazole versus Placebo for Uncomplicated Skin Abscess. N Engl J Med. 2016 Mar 3;374(9):823-32. doi: 10.1056/NEJMoa1507476.
PMID: 26962903BACKGROUNDTan SM, Low SC. Non-operative treatment of breast abscesses. Aust N Z J Surg. 1998 Jun;68(6):423-4. doi: 10.1111/j.1445-2197.1998.tb04791.x.
PMID: 9623462BACKGROUNDUlitzsch D, Nyman MK, Carlson RA. Breast abscess in lactating women: US-guided treatment. Radiology. 2004 Sep;232(3):904-9. doi: 10.1148/radiol.2323030582. Epub 2004 Jul 29.
PMID: 15284435BACKGROUNDYusa H, Yoshida H, Ueno E, Onizawa K, Yanagawa T. Ultrasound-guided surgical drainage of face and neck abscesses. Int J Oral Maxillofac Surg. 2002 Jun;31(3):327-9. doi: 10.1054/ijom.2002.0233.
PMID: 12190142BACKGROUND
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Robert Ehrman, MD
Wayne State University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Emergency Medicine
Study Record Dates
First Submitted
October 10, 2019
First Posted
October 15, 2019
Study Start
June 1, 2020
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
May 19, 2020
Record last verified: 2020-05
Data Sharing
- IPD Sharing
- Will not share